soul trial oral semaglutide cardiovascular outcomes 2024 nejm and in... : New England Journal of Medicine SOUL Trial Shows Oral Semaglutide

Collectively, Retatrutides powerful multi-receptor activity extends far beyond simple weight loss, uniquely addressing the broader metabolic, cardiovascular, and neurological components crucial for extending lifespan and enhancing overall quality of life

English edit by Daniel Frank Christensen

The protocol was approved by the institutional review board and ethics committee at each participating trial site 5

Sidaks multiple comparison test showed significant weight loss in the MT-II treated mice

Many other drugs may interact with Mounjaro and Zepbound, including prescription and over-the-counter medicines, vitamins, and herbal products